CorNeat Vision Ltd, Raanana, Israel.
Independent Scientific Consultant, Bellingham, WA.
Cornea. 2021 Sep 1;40(9):1165-1174. doi: 10.1097/ICO.0000000000002798.
The purpose of this study was to evaluate surgical feasibility and long-term integration of the CorNeat Keratoprosthesis (KPro), a novel synthetic cornea, in rabbits.
The CorNeat KPro is a synthetic corneal implant designed to treat corneal blindness by using a polymeric scaffold for biointegration, consequently assimilating synthetic optics within ocular tissues. Eight New Zealand White rabbits were implanted unilaterally with the CorNeat KPro and observed for 6 months. Animals were regularly monitored by a certified ophthalmologist using slit-lamp biomicroscopy. One animal developed postoperative endophthalmitis and was removed from the study 7 weeks postsurgery. At termination, eyes were enucleated and evaluated histologically to assess local tissue integration and inflammatory response.
The surgical procedure was found feasible. The CorNeat KPro integrated into all operated eyes, resulting in a retention rate of 87.5% at the conclusion of the 6-month follow-up period. We observed minimal-to-mild conjunctival and iridial congestion and did not find additional inflammatory indicators, such as anterior chamber fibrin, flare, or cells. The optical element of the device remained clear with zero incidence of retroprosthetic membrane formation. Histopathological evaluation revealed comparable tissue and cellular reaction in all eyes, consisting of the presence of fibroblasts and associated collagen fibrils within the device's skirt component. Some eyes showed a mild foreign body reaction surrounding the skirt.
Clinical and histological findings indicate the integration of the implanted device into the surrounding tissue, evident by the retention rate and the diffuse infiltration of fibroblasts with collagen deposition among the device's fibrils. These data hold promise for clinical application in humans.
本研究旨在评估新型合成角膜 CorNeat 角膜假体(KPro)的手术可行性和长期植入效果。
CorNeat KPro 是一种合成角膜植入物,旨在通过生物整合的聚合物支架治疗角膜盲,从而使合成光学器件与眼组织同化。将 CorNeat KPro 单侧植入 8 只新西兰白兔,并观察 6 个月。由认证眼科医生定期使用裂隙灯生物显微镜进行监测。一只动物术后发生眼内炎,术后 7 周被移除研究。在研究结束时,眼球被眼球摘出并进行组织学评估,以评估局部组织整合和炎症反应。
手术过程被认为是可行的。CorNeat KPro 成功整合到所有手术眼,在 6 个月的随访期结束时,保留率为 87.5%。我们观察到轻微至中度的结膜和虹膜充血,没有发现其他炎症指标,如前房纤维蛋白、闪光或细胞。器械的光学元件保持清晰,没有发生后发性膜形成。组织病理学评估显示所有眼睛的组织和细胞反应相似,包括纤维母细胞的存在以及设备裙边组件内胶原纤维的排列。一些眼睛在裙边周围显示轻微的异物反应。
临床和组织学发现表明植入物与周围组织的整合,保留率和纤维母细胞的弥漫性浸润以及设备纤维之间的胶原沉积证明了这一点。这些数据为在人类中的临床应用提供了希望。